4th Quarter - Report
NATIONAL ORGANIZATION FOR RARE DISORDERS, INC. (NORD) for NATIONAL ORGANIZATION FOR RARE DISORDERS INC (NORD)
Income
—
Expenses
$50,000
Expense method
B: tax-exempt organisations, Internal Revenue Code section 6033(b)(8)
What was lobbied
3 issue areas, each in the filer's own words, with who lobbied on it and where.
Medicare/Medicaid MMM
Medicare / Medicaid issues impacting patients with rare diseases. Inflation Reduction Act Implementation.
| Lobbyist | Covered position, as disclosed |
|---|---|
| MASON OLIVER BARRETT | — |
| HAYLEY DEMPSEY | — |
| HEIDI ROSS | — |
Pharmacy PHA
Pharmaceutical issues impacting patients with rare diseases. Orphan Drug Act. Inflation Reduction Act Implementation. PRV Reauthorization.
| Lobbyist | Covered position, as disclosed |
|---|---|
| MASON OLIVER BARRETT | — |
| HAYLEY DEMPSEY | — |
| HEIDI ROSS | — |
Health Issues HCR
Rare Disease Initiatives. Affordable Care Act (ACA) Issues and Enhancements. Telehealth. Priority Review Voucher Reauthorization. Lab-developed tests. H.R.4758/S.2372: Accelerating Kids Access to Care Act.
| Lobbyist | Covered position, as disclosed |
|---|---|
| MASON OLIVER BARRETT | — |
| HAYLEY DEMPSEY | — |
| HEIDI ROSS | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.